These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Severe GHB withdrawal delirium managed with dexmedetomidine. Tay EM; Graham RI; Day RO Med J Aust; 2016 Sep; 205(6):251-2. PubMed ID: 27627929 [No Abstract] [Full Text] [Related]
7. Successful Management of Gamma-hydroxybutyrate (GHB) Withdrawal Using Baclofen as a Standalone Therapy: A Case Report. Habibian S; Ahamad K; McLean M; Socias ME J Addict Med; 2019; 13(5):415-417. PubMed ID: 30907765 [TBL] [Abstract][Full Text] [Related]
8. [GHB withdrawal delirium]. Stijnenbosch PJ; Zuketto C; Beijaert PJ; Maat A Ned Tijdschr Geneeskd; 2010; 154():A1086. PubMed ID: 20132572 [TBL] [Abstract][Full Text] [Related]
9. Phenobarbital to manage severe gamma-hydroxybutyrate withdrawal: A case series. Freeman G; Siefried KJ; Roberts DM; Rodgers C; Nic Ionmhain U; Ramanathan J; Ezard N; Brett J Drug Alcohol Rev; 2023 Jan; 42(1):27-32. PubMed ID: 36269081 [TBL] [Abstract][Full Text] [Related]
10. Gamma-hydroxybutyrate withdrawal syndrome: dangerous but not well-known. van Noorden MS; van Dongen LC; Zitman FG; Vergouwen TA Gen Hosp Psychiatry; 2009; 31(4):394-6. PubMed ID: 19555805 [TBL] [Abstract][Full Text] [Related]
11. Treatment of Gamma Hydroxybutyrate Withdrawal in a Pregnant Female: A Case Report. Joyce S; Lea S; Woolner M; Leddy A J Addict Med; 2024 May-Jun 01; 18(3):342-344. PubMed ID: 38345233 [TBL] [Abstract][Full Text] [Related]
12. Excited delirium syndrome after withdrawal from 10 days long recreationally used GHB. Corstens D J Forensic Leg Med; 2018 Feb; 54():74-75. PubMed ID: 29328965 [TBL] [Abstract][Full Text] [Related]
13. Two cases of severe gamma-hydroxybutyrate withdrawal delirium on a psychiatric unit: recommendations for management. Rosenberg MH; Deerfield LJ; Baruch EM Am J Drug Alcohol Abuse; 2003 May; 29(2):487-96. PubMed ID: 12765217 [TBL] [Abstract][Full Text] [Related]
14. The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol. Schep LJ; Knudsen K; Slaughter RJ; Vale JA; Mégarbane B Clin Toxicol (Phila); 2012 Jul; 50(6):458-70. PubMed ID: 22746383 [TBL] [Abstract][Full Text] [Related]
15. Enteral baclofen withdrawal managed with intravenous dexmedetomidine: A case report. Defayette A; Perrello A; Brewer T; Picano J; Ahmed S Am J Health Syst Pharm; 2020 Feb; 77(5):352-355. PubMed ID: 31930325 [TBL] [Abstract][Full Text] [Related]
16. Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal. Miotto K; Darakjian J; Basch J; Murray S; Zogg J; Rawson R Am J Addict; 2001; 10(3):232-41. PubMed ID: 11579621 [TBL] [Abstract][Full Text] [Related]
17. Severe gamma-hydroxybutyrate withdrawal: a case report and literature review. Craig K; Gomez HF; McManus JL; Bania TC J Emerg Med; 2000 Jan; 18(1):65-70. PubMed ID: 10645841 [TBL] [Abstract][Full Text] [Related]
18. gamma-Hydroxybutyrate withdrawal and chloral hydrate. Hutto B; Fairchild A; Bright R Am J Psychiatry; 2000 Oct; 157(10):1706. PubMed ID: 11007738 [No Abstract] [Full Text] [Related]
19. Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review. McDonough M; Kennedy N; Glasper A; Bearn J Drug Alcohol Depend; 2004 Jul; 75(1):3-9. PubMed ID: 15225884 [TBL] [Abstract][Full Text] [Related]